Loading…
Loading…
LifeMD (NASDAQ: LFMD - Get Free Report) and Ryman Healthcare (OTCMKTS:RYHTY - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, profitability and analyst recommendations. Valuation and Earnings This table compares LifeMD and
Ryman Healthcare Limited (RYHTY) Shareholder/Analyst Call Transcript
Ryman Healthcare Limited (RYHTY) Analyst/Investor Day Transcript
CVS Health (NYSE: CVS - Get Free Report) and Ryman Healthcare (OTCMKTS:RYHTY - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends. Valuation and Earnings This table compares CVS Health
Enhabit (NYSE: EHAB - Get Free Report) and Ryman Healthcare (OTCMKTS:RYHTY - Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations. Profitability This table compares Enhabit and Ryman Healthcare's net
Ryman Healthcare Limited (OTCPK:RYHTY) Q2 2026 Earnings Call November 26, 2025 5:00 PM EST Company Participants Naomi James - Chief Executive Officer Hayden Strickett Matthew Prior - Chief Financial Officer Conference Call Participants Bianca Fledderus - UBS Investment Bank, Research Division Arie Dekker - Jarden Limited, Research Division Will Twiss - Forsyth Barr Group Ltd., Research Division Stephen Ridgewell - Craigs Investment Partners Limited, Research Division Nick Mar - Macquarie Research Presentation Operator Thank you for standing by, and welcome to the Ryman Healthcare Half Year Results Briefing.
Ryman Healthcare Limited (OTCPK:RYHTY) Q4 2025 Results Conference Call May 28, 2025 7:00 PM ET Company Participants Naomi James - Chief Executive Officer Rob Woodgate - Chief Financial Officer Hayden Strickett - Head of Investor Relations Conference Call Participants Arie Dekker - Jarden Bianca Murphy - UBS Aaron Ibbotson - Forsyth Barr Nick Mar - Macquarie Stephen Ridgewell - Craigs Investment Partners Operator Thank you for standing by, and welcome to Ryman Healthcare Full Year Results Briefing. [Operator Instructions] I would now like to hand the conference over to Ms.
Ryman Healthcare Limited (OTCPK:RYHTY) Q2 2025 Earnings Conference Call November 27, 2024 4:00 PM ET Company Participants Dean Hamilton - Executive Chairman Rob Woodgate - Chief Financial Officer Naomi James - Chief Executive Officer Conference Call Participants Arie Dekker - Jarden Bianca Fledderus - UBS Aaron Ibbotson - Forsyth Barr Stephen Ridgewell - Craigs Investment Partners Nick Mar - Macquarie Operator Thank you for standing by and welcome to the Ryman Healthcare Half Year Results Briefing. All participants are in a listen-only mode.
No recent filings indexed.